Log In
BCIQ
Print this Print this
 

P7170

  Manage Alerts
Collapse Summary General Information
Company Piramal Enterprises Ltd.
DescriptionOrally active PI3K/mTOR and ALK-1 inhibitor with anti-tumour and anti-angiogenic activity
Molecular Target Phosphoinositide 3-kinase (PI3K) ; Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)
Mechanism of ActionMammalian target of rapamycin (mTOR) kinase inhibitor; Phosphoinositide 3-kinase (PI3K) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today